Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|November 16, 2021
A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T CellsWenyue Cao, Zhi Zachary Geng, Na Wang, et al.Journal of Molecular Biology|March 12, 2022
A Designed, Highly Efficient Pyrrolysyl-tRNA Synthetase Mutant Binds o-Chlorophenylalanine Using Two Halogen BondsErol C Vatansever, Kai S Yang, Zhi Zachary Geng, et al.Current Research in Chemical Biology|July 11, 2022
Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main proteaseKai S Yang, Syuan-Ting Alex Kuo, Lauren R Blankenship, et al.ACS Central Science|April 29, 2024
Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein InhibitorsPeng-Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.Nucleic Acids Research|June 9, 2023
An amber-encoding helper phage for more efficient phage display of noncanonical amino acidsJoshua Trae Hampton, Chia-Chuan Dean Cho, Demonta D Coleman, et al.Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 O - Tert -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.Biorxiv : the Preprint Server for Biology|January 4, 2022
The N -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease InhibitorsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.European Journal of Medicinal Chemistry|July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antiviralsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.Pageof 2